Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiotherapy for Meningiomas - Where Do We Stand and What's on the Horizon?
Ehret F, Baya LE, Erridge SC, Bussière M, Verhoeff J, Niyazi M, Preusser M, Minniti G, Shih HA. Ehret F, et al. Among authors: preusser m. Int J Radiat Oncol Biol Phys. 2024 Oct 28:S0360-3016(24)03525-9. doi: 10.1016/j.ijrobp.2024.10.034. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39476990 Free article. Review.
Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Le Rhun E, Weller M, van den Bent M, Brandsma D, Furtner J, Rudà R, Schadendorf D, Seoane J, Tonn JC, Wesseling P, Wick W, Minniti G, Peters S, Curigliano G, Preusser M; EANO Guidelines Committee and ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Le Rhun E, et al. Among authors: preusser m. ESMO Open. 2023 Oct;8(5):101624. doi: 10.1016/j.esmoop.2023.101624. Epub 2023 Sep 19. ESMO Open. 2023. PMID: 37863528 Free PMC article.
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups.
Karschnia P, Smits M, Reifenberger G, Le Rhun E, Ellingson BM, Galldiks N, Kim MM, Huse JT, Schnell O, Harter PN, Mohme M; Expert Rater Panel; von Baumgarten L, Albert NL, Huang RY, Mehta MP, van den Bent M, Weller M, Vogelbaum MA, Chang SM, Berger MS, Tonn JC. Karschnia P, et al. Lancet Oncol. 2023 Nov;24(11):e438-e450. doi: 10.1016/S1470-2045(23)00453-9. Lancet Oncol. 2023. PMID: 37922934 Free PMC article. Review.
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short SC, Smits M, Suchorska B, Tolboom N, Traub-Weidinger T, Tonn JC, Verger A, Weller M, Wen PY, Preusser M. Albert NL, et al. Among authors: preusser m. Lancet Oncol. 2024 Jan;25(1):e29-e41. doi: 10.1016/S1470-2045(23)00525-9. Lancet Oncol. 2024. PMID: 38181810 Review.
Translating the theranostic concept to neuro-oncology: disrupting barriers.
Albert NL, Le Rhun E, Minniti G, Mair MJ, Galldiks N, Tolboom N, Jakola AS, Niyazi M, Smits M, Verger A, Cicone F, Weller M, Preusser M; European Organisation for Research and Treatment of Cancer Brain Tumor Group. Albert NL, et al. Among authors: preusser m. Lancet Oncol. 2024 Sep;25(9):e441-e451. doi: 10.1016/S1470-2045(24)00145-1. Lancet Oncol. 2024. PMID: 39214115 Review.
PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives.
Cella E, Bosio A, Persico P, Caccese M, Padovan M, Losurdo A, Maccari M, Cerretti G, Ius T, Minniti G, Idbaih A, Sanai N, Weller M, Preusser M, Simonelli M, Lombardi G. Cella E, et al. Among authors: preusser m. Cancer Treat Rev. 2024 Dec;131:102850. doi: 10.1016/j.ctrv.2024.102850. Epub 2024 Nov 5. Cancer Treat Rev. 2024. PMID: 39531943 Free article. Review.
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
Tabouret E, Furtner J, Graillon T, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M. Tabouret E, et al. Among authors: preusser m. Neuro Oncol. 2024 Jul 5;26(7):1302-1309. doi: 10.1093/neuonc/noae037. Neuro Oncol. 2024. PMID: 38452246 Clinical Trial.
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042.
Maas SLN, Sievers P, Weber DC, Weller M, van den Bent MJ, Mair MJ, Kros JM, Carparrotti F, von Deimling A, Salvador VF, Peerdeman SM, Casas-Martin J, Gorlia T, Sahm F, Preusser M. Maas SLN, et al. Among authors: preusser m. Acta Neuropathol. 2023 Dec;146(6):837-840. doi: 10.1007/s00401-023-02642-5. Epub 2023 Oct 19. Acta Neuropathol. 2023. PMID: 37855895 Free PMC article. No abstract available.
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma.
Maas SLN, Hielscher T, Sievers P, Hovestadt V, Suwala AK, Acker T, Weller M, Preusser M, Herold-Mende C, Wick W, von Deimling A, Berghaus N, Sahm F. Maas SLN, et al. Among authors: preusser m. Acta Neuropathol. 2024 Aug 8;148(1):17. doi: 10.1007/s00401-024-02777-z. Acta Neuropathol. 2024. PMID: 39115604 Free PMC article. No abstract available.
Corrigendum to "Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial" [Eur J Cancer 198 (2024) 113475].
Le Rhun E, Gorlia T, Felsberg J, Jongen J, Maurage CA, Ducray F, Gramatzki D, Hau P, Chinot OL, Preusser M, Cartalat S, Roth P, van den Bent M, Furtner J, Collienne M, Reifenberger G, Weller M. Le Rhun E, et al. Among authors: preusser m. Eur J Cancer. 2024 Jun;204:114066. doi: 10.1016/j.ejca.2024.114066. Epub 2024 Apr 23. Eur J Cancer. 2024. PMID: 38658199 Free article. No abstract available.
525 results